FDA Made Right Call On Ambien Sleep Driving Risk: Doctors
A group of doctors support FDA's decision and use of data in making label changes and dosage change recommendations for Ambien and other insomnia drugs.
A group of doctors support FDA's decision and use of data in making label changes and dosage change recommendations for Ambien and other insomnia drugs.
Federal drug regulators have approved a new warning label update for sleeping drugs like Ambien, recommending lower doses to reduce the risk of users experiencing problems associated with lingering effects…
The consumer watchdog group Public Citizen is warning that side effects of Intermezzo, a shorter acting version of the sleeping drug Ambien, may carry similar safety risks the next morning…